Hanmei Li

Prof. Dr. Hanmei Li

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
BNBoris Nikolaev
Boris Nikolaev
LYLudmila Yakovleva
Ludmila Yakovleva
VFViacheslav Fedorov
Viacheslav Fedorov
HLHanmei Li
Hanmei Li
huile gaohuile gao
huile gao
Maxim ShevtsovMaxim Shevtsov
Maxim Shevtsov
Nano- and microemulsions are colloidal systems that are widely used in various fields of biomedicine, including wound and burn healing, cosmetology, the development of antibacterial and antiviral drugs, oncology, etc. The stability of these systems is governed by the balance of molecular interactions between nanodomains. Microemulsions as a colloidal form play a special important role in stability. The microemulsion is the thermodynamically stable phase from oil, water, surfactant and co-surfactant which forms the surface of drops with very small surface energy. The last phenomena determines the shortage time of all fluid dispersions including nanoemulsions and emulgels. This review examines the theory and main methods of obtaining nano- and microemulsions, particularly focusing on the structure of microemulsions and methods for emulsion analysis. Additionally, we have analyzed the main preclinical and clinical studies in the field of wound healing and the use of emulsions in cancer therapy, emphasizing the prospects for further developments in this area.

9 February 2023 in Journal of Controlled Release
Verified
Journal Article
Closed access
WLWei Li
Wei Li
LCLiang Chen
Liang Chen
ZGZhongwei Gu
Zhongwei Gu
ZCZhoujiang Chen
Zhoujiang Chen
HLHong Li
Hong Li
LZLiang Zou
Liang Zou

3 May 2024 in Journal of Controlled Release
Verified
Journal Article
Closed access
LYLianyi Yang
Lianyi Yang
YWYazhen Wang
Yazhen Wang
Yujun SongYujun Song
Yujun Song
ZLZeya Li
Zeya Li
LLLei Lei
Lei Lei
huile gaohuile gao
huile gao

21 October 2022 in Frontiers in Public Health
Verified
Journal Article
Open access
JHJiajia Huang
Jiajia Huang
HLHanmei Li
Hanmei Li
HYHualing Yan
Hualing Yan
FLFen-Xiang Li
Fen-Xiang Li
MTMai Tang
Mai Tang
DLDa-Lin Lu
Da-Lin Lu
Background: Brain and central nervous system (CNS) cancers represent a major source of cancer burden in China and the United States. Comparing the two countries' epidemiological features for brain and CNS cancers can help plan interventions and draw lessons.Methods: Data were extracted from the Global Burden of Disease repository. The average annual percentage change (AAPC) and relative risks of cancer burdens were calculated using joinpoint regression analysis and age-period-cohort (APC) models, respectively. Moreover, a Bayesian APC model was employed to predict the disease burden over the next decade.Results: From 1990 to 2019, the number of incidences, deaths, and disability-adjusted life-years (DALYs) increased in China and the US, with a larger increase in China. Age-standardized incidence rates in China and the United States have shown an increasing trend over the past three decades, with AAPCs of 0.84 and 0.16%, respectively. However, the rates of age-standardized mortality and age-standardized DALYs decreased in both countries, with a greater decrease in China. Overall, age trends in cancer burden were similar for males and females, with two peaks in the childhood and elderly groups, respectively. The period and cohort effects on incidence showed an overall increasing trend in China and limited change in the US. However, the period effects for mortality and DALY were decreasing in both countries, while the cohort effects tended to increase and then decrease. Moreover, we predicted that the cancer burdens would continue to rise in China over the next decade.Conclusion: The burden of brain and CNS cancers is substantial and will continue to increase in China. Comprehensive policy and control measures need to be implemented to reduce the burden.

1 July 2024 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
JZJuying Zhang
Juying Zhang
XLXia Luo
Xia Luo
XYXin Yang
Xin Yang
HLHanmei Li
Hanmei Li
QJQiong Jiang
Qiong Jiang
JYJinhong Yu
Jinhong Yu
Purpose: The incidence of hepatocellular carcinoma (HCC) is continuously increasing, and the mortality rate remains high. Thus, more effective strategies are needed to improve the treatment of HCC. Methods: In this study, we report the use of a visualized glypican-3 (GPC3)-targeting nanodelivery system (named GC-NBs) in combination with sonodynamic therapy (SDT) to enhance the therapeutic efficacy for treating HCC. The obtained nanodelivery system could actively target hepatocellular carcinoma cells and achieve ultrasound imaging through phase changes into nanobubbles under low-intensity ultrasound irradiation. Meanwhile, the released chlorine e6 (Ce6) after the nanobubbles collapse could lead to the generation of reactive oxygen species (ROS) under ultrasound irradiation to induce SDT. Results: Both in vitro and in vivo experiments have shown that GC-NBs can accumulate in tumour areas and achieve sonodynamic antitumour therapy under the navigation action of glypican-3-antibody (GPC3-Ab). Furthermore, in vitro and in vivo experiments did not show significant biological toxicity of the nanodelivery system. Moreover, GC-NBs can be imaged with ultrasound, providing personalized treatment monitoring. Conclusion: GC-NBs enable a visualized antitumour strategy from a targeted sonodynamic perspective by combining tumour-specific targeting and stimuli-responsive controlled release into a single system.

20 July 2022 in Molecules
Verified
Journal Article
Open access
PDF file
CTChuane Tang
Chuane Tang
DYDan Yin
Dan Yin
TLTianya Liu
Tianya Liu
RGRui Gou
Rui Gou
JFJiao Fu
Jiao Fu
HLHanmei Li
Hanmei Li
Cell surface thiols can be targeted by thiol-reactive groups of various materials such as peptides, nanoparticles, and polymers. Here, we used the maleimide group, which can rapidly and covalently conjugate with thiol groups, to prepare surface-modified liposomes (M-Lip) that prolong retention of doxorubicin (Dox) at tumor sites, enhancing its efficacy. Surface modification with the maleimide moiety had no effect on the drug loading efficiency or drug release properties. Compared to unmodified Lip/Dox, M-Lip/Dox was retained longer at the tumor site, it was taken up by 4T1 cells to a significantly greater extent, and exhibited stronger inhibitory effect against 4T1 cells. The in vivo imaging results showed that the retention time of M-Lip at the tumor was significantly longer than that of Lip. In addition, M-Lip/Dox also showed significantly higher anticancer efficacy and lower cardiotoxicity than Lip/Dox in mice bearing 4T1 tumor xenografts. Thus, the modification strategy with maleimide may be useful for achieving higher efficient liposome for tumor therapy.